Innate immunity is a phylogenetically ancient system of host defense and represents the inherited resistance to infection (75) . Until relatively recently, the innate immune response was viewed as a nonspecific and temporary expedient to Ôbuy timeÕ until the activation of adaptive immunity, which comprises the system of B and T lymphocytes, each of which expresses antigen receptors of exquisite specificity (41) . Although lacking the ability to make such fine structural distinctions, innate immunity is nevertheless endowed with considerable specificity. Indeed, germline-encoded receptors (collectively known as pattern-recognition receptors) can detect and respond to conserved and generally distinct microbial structures that are shared by related groups of microorganisms (e.g. lipopolysaccharide of gramnegative bacteria or lipoteichoic acid of gram-positive bacteria) (105) . Most importantly, innate immunity is sophisticated enough to make judgments that instruct the initiation and progression of the adaptive immune response (41, 105) . In this regard, the acquired specificity of the antigen receptors is not the result of coevolution with microbes but the outcome of randomly generated gene recombination. Thus, even though the adaptive immune receptors can bind virtually any structure, they have no clue on the biological context of the encountered antigen (i.e. should they respond or not?). This information, however, is provided by innate immune mechanisms, which act as mediators between detection of infection and induction of the adaptive response. Not surprisingly, therefore, successful pathogens, which disarm or subvert host defenses, target preferentially innate immunity (42) and particularly central systems such as the complement system and the Toll-like receptor (TLR) family of pattern-recognition receptors (96, 140) .
In the oral cavity, innate immunity contributes significantly to antimicrobial defense, although inadequate or over-exuberant activation of the innate response may lead to oral disease, such as periodontitis (36, 53) . In this context, periodontal health represents a dynamic state where proinflammatory and antimicrobial activities to control infection are optimally balanced by anti-inflammatory mechanisms to prevent unwarranted inflammation (43) . This homeostatic balance may be disrupted, however, either by genetic defects in host immunity or by pathogens that undermine host-defense mechanisms (43, 89, 93) . It should be noted that pathogen-instigated immune suppression of specific pathways and destructive inflammatory responses in the periodontium are not necessarily mutually exclusive, because the latter may arise as a consequence of the inability to control infection (52) .
This review focuses on two key innate immune components -the complement system and the TLRs -and discusses how these systems interact with each other and with periodontal bacteria. The ability of periodontal pathogens to persist and establish chronic infections suggests that they may have evolved ways to disarm these defense mechanisms or subvert them to their advantage. Understanding the mechanisms of periodontal host-pathogen interplay can offer important insights into the disease pathogenesis and facilitate the rational design of therapeutic interventions. A brief background on complement and TLR biology is presented below to facilitate the discussion on their interactions with periodontal bacteria.
Complement, TLRs and potential for crosstalk
The term ÔcomplementÕ was coined by Paul Ehrlich in the late 1890s to describe a heat-sensitive activity in serum that is complementary to that of antibody in causing lysis of bacteria (153) . In line with this early view, the complement has been traditionally considered as an antimicrobial enzyme system found in serum and inflammatory exudates such as the gingival crevicular fluid (7, 110, 123) . However, it is now well appreciated that complement constitutes a fundamental component of innate immunity, by virtue of its ability to orchestrate critical events during immune and inflammatory responses, including the regulation of other innate or adaptive immune pathways (67, 98, 103, 183) .
The triggering of the complement system involves the sequential activation and proteolytic cleavage of a series of serum proteins, leading to recruitment and activation of inflammatory cells, microbial opsonization and phagocytosis, and direct lysis of targeted pathogens (103) . In addition to the serum components, the integrated complement system also includes membrane-bound regulators and receptors for interactions with various mediators of the immune system. Complement activation can proceed through three distinct mechanisms, namely the classical, lectin, or alternative pathways (103) (Fig. 1) . All three pathways converge at a central step, involving activation of the third component of complement (C3) by pathway-specific C3 convertases (95, 103) . The activation of the classical pathway is initiated by antigen-antibody complexes, whereas the lectin pathway is triggered through the interaction of a secreted pattern-recognition receptor (the mannose-binding lectin) with specific carbohydrate groups on the surface of a variety of microorganisms. To ensure a fast and immediate response to invading pathogens, the complement cascade is maintained at a low level of activity (Ôtick-overÕ) by the so-called alternative pathway. This pathway is initiated by spontaneous hydrolysis of C3 to C3(H 2 O), thereby inducing a conformational change that allows binding to complement factor B and formation of the initial alternative pathway C3 convertase. This results in the rapid propagation of the alternative pathway, as long as there is no sufficient negative regulation as normally occurs with nonself surfaces (e.g. bacteria). In addition to this mechanism, the alternative pathway can be induced by bacterial lipopolysaccharide and lipooligosaccharide molecules in a way that strictly requires the participation of the plasma protein properdin (86) . The alternative pathway may 
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C5b MAC C5b-9 Terminal pathway C5L2 ? C6-9 Fig. 1. Activation pathways of the complement system. All three pathways converge at a central step, involving activation of the third component of complement (C3) by pathway-specific C3 convertases. The classical pathway is initiated by antigen-antibody (Ag-Ab) complexes and requires the participation of C1, C2 and C4. The lectin pathway is triggered through interaction of the mannosebinding lectin (MBL) with specific carbohydrate groups on the surface of microorganisms. The alternative pathway is initiated by spontaneously hydrolyzed C3 [C3(H 2 O)], which can thereby form a complex with factor B, followed by factor B cleavage by factor D and formation of the initial alternative pathway C3 convertase (103) . Moreover, the alternative pathway can be induced by bacterial lipopolysaccharide and lipooligosaccharide in a properdindependent manner (86) . Proteolytic cleavage of a series of proteins downstream of C3 leads to the generation of potent effector molecules. These include the anaphylatoxins C3a and C5a, which activate specific receptors (C3aR and C5aR, respectively), although C5a also interacts with the so-called C5a receptor-like 2 (C5L2), which is only modestly characterized (91) . Additional effectors generated downstream of C3 are the opsonins C3b and iC3b, the latter of which coats microbes and promotes their phagocytosis by complement receptor-3 (CR3). In the terminal pathway, C5b initiates the assembly of the C5b-9 membrane attack complex (MAC), which in turn induces microbial cell lysis (103) . Complement activation can also occur through crosstalk with other physiological pathways, such as the coagulation system, in which thrombin acts as a C5 convertase (71) .
represent up to 80% of complement activation (103) . In all three pathways, proteolytic cleavage of a series of proteins downstream of C3 leads to the generation of effector molecules, including opsonins (C3b, iC3b) and anaphylatoxins (C3a, C5a). The iC3b fragment is generated by further cleavage of microbe-attached C3b and mediates phagocytosis by complement receptor-3 (Fig. 1) . The inflammatory anaphylatoxins C3a and C5a activate seven-transmembrane domain G-protein-coupled receptors, known as the C3a receptor and C5a receptor (CD88), respectively. A newly identified, but modestly characterized, alternative receptor for C5a is the so-called C5a receptor-like 2; this was originally believed to be an anti-inflammatory decoy receptor, but is now thought to play a novel and distinct role in sepsis (173) . Another C5 cleavage product, C5b, initiates the assembly of the C5b-9 membrane attack complex, which induces lysis of complement-targeted bacteria (103) (Fig. 1) .
TLRs comprise a family of pattern recognition receptors named after their similarity to the Drosophila Toll protein (99, 106) . Their discovery, in the late 1990s, has sparked a resurgent interest in innate immunity. Indeed, the study of TLRs has helped us to appreciate the economical specificity of the innate immune system and that adaptive immunity did not evolve to replace innate immunity, but rather evolved around it. TLRs are transmembrane glycoproteins comprising an N-terminal leucine-rich repeat domain, a transmembrane region and a C-terminal cytoplasmic signaling domain (76, 84) . These receptors are primarily expressed by first-line professional phagocytes (e.g. neutrophils, macrophages and dendritic cells) and are thus strategically located for early recognition of microbial pathogens (1). To date, 10 human TLRs have been identified that generally sense and respond to distinct types of microbial structures (Fig. 2) . For instance, TLR3 responds to double-stranded viral RNA, TLR4 responds to enterobacterial lipopolysaccharide, TLR5 responds to bacterial flagellin and TLR9 responds to microbial CpG DNA. TLR2 is unique in that it heterodimerizes with signaling partners (TLR1 or TLR6) for detecting and responding to microbial cell-wall components, such as lipoteichoic acid, lipoproteins, fimbriae, or yeast zymosan (1, 12, 90) . TLRs (e.g. TLRs 1, 2, 4, 5 and 6) that are mainly responsible for detecting extracellular microbial structures are expressed on the host cell surface, whereas those (e.g. TLRs 3, 7, 8 and 9) specializing in detecting viral or bacterial nucleic acids are appropriately located intracellularly on endocytic vesicles or organelles (Fig. 2 118, 119) . The presence of both common and selective adaptors, in conjunction with the apparent compartmentalization of the TLRs, allows the induction of individual signaling pathways (for at least some TLRs) in addition to a core TLR response (119) . It is thus possible that activation of diverse TLR intracellular pathways, dependent upon different TLR ligand specificities, may allow the host to tailor a response that is appropriate against a given pathogen.
Both complement and TLRs are rapidly activated by most pathogens upon encounter with the host, and common microbial molecules, such as gramnegative bacterial lipopolysaccharide and yeast zymosan, can act both as TLR ligands and complement activators. It is conceivable that the coordination of the early innate response would require a crosstalk between the complement system and the TLR system. In this regard, a systematic analysis of crosstalk in intracellular signaling pathways has revealed that a great number of microbe-induced stimuli converge on a relatively limited number of effector signaling pathways (115) . In principle, a molecular crosstalk between complement and TLRs could result in cross-regulation of the two systems, including potential synergistic, or even antagonistic, interactions. These interactions may help enhance host defense or regulate it to prevent excessive inflammatory responses. However, it is also plausible that at least some crosstalk interactions may be instigated by the pathogens themselves for deregulating or modifying the host response in a way that favors their survival. Although this issue has only recently started to be addressed, available evidence indicates bidirectional cooperation between the complement system and the TLR system, because complement regulates TLR activation (67, 183) , whereas TLR signaling transmodulates the activity of complement receptors (60, 63) .
Periodontitis, associated bacteria and complement ⁄ TLR immunity
Periodontal disease is possibly the most common chronic disorder of infectious origin in humans, resulting in inflammatory destruction of the toothsupporting tissues (125) . The disease is initiated by certain species of subgingival gram-negative anaerobic bacteria that co-exist within dynamic communities of highly organized architecture (31, 158) , originally termed Ôdental plaqueÕ, which predates the more modern term ÔbiofilmÕ (46, 108) . In fact, seldom would discussions on pathogenic biofilms omit the classical example of dental plaque (25, 88) . In periodontal health, the ordered structure of the dental plaque biofilm consists predominately of gram-positive, facultative anaerobic bacteria, although the onset of the disease is associated with a shift to gram-negative anaerobic bacteria, which begin to colonize the subgingival pocket with greater frequencies (157) . Using a color-coded system, Socransky and colleagues (158) characterized these microbial communities as red, orange, green, purple and yellow complexes, on the basis of cluster analysis, community ordination and associated disease severity. The presence of high numbers of red complex members such as Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia correlates strongly with periodontal tissue destruction (70, 158) . Prevotella intermedia and Fusobacterium nucleatum, both members of the orange complex, are also associated with various forms of periodontal disease (28, 158, 178) .
While the bacteria constitute an essential etiologic factor, it is the host inflammatory reaction to bacterial challenge that primarily mediates periodontal tissue damage (43) . This is not to say, however, that the challenge in periodontitis involves simply the issue of controlling the inflammatory response. In a related context, purely anti-inflammatory therapies in sepsis clinical trials have generally failed, even if the initial hyperinflammatory stage was controlled; indeed, many patients would succumb to the infection itself at later stages of the disease (137) . Therefore, periodontal and other infection-driven inflammatory diseases should be dealt with in ways that address both infection and inflammation. This, in turn, requires an adequate understanding of both protective and destructive aspects of the host response, and how pathogens may evade the former and contribute to the latter.
There is strong evidence that complement and TLRs form an important link between infection and various local or systemic autoimmune or inflammatory conditions, such as septic shock, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, atherosclerosis, ischemia ⁄ reperfusion injury and asthma (3, 16, 24, 135, 172) . There is also evidence to support the involvement of the complement and TLR systems in periodontitis. In this regard the complement is abundant in the gingival crevicular fluid, where it is present at up to 70% of its concentration found in serum (130) . Activated complement fragments are abundant in the gingival crevicular fluid of periodontitis patients, whereas they are absent or present in lower concentrations in the crevicular fluid from healthy individuals (7, 17, 147, 148) . The functionality of the complement components of the gingival crevicular fluid has been confirmed (26) , whereas activated complement fragments have also been detected in the gingival connective tissue (26) . Importantly, induction of experimental gingivitis in human volunteers causes progressive elevation of complement cleavage products and correlates with increased accumulation of microbial plaque, clinical inflammation and bleeding on probing (123) . These clinical findings suggest a role for the involvement of complement in periodontal pathogenesis. Moreover, in vitro mechanistic studies have demonstrated complex interactions between periodontal bacteria and the complement system (61, 104, 127, 130, 156) .
In addition to elevated complement activity, the inflamed periodontium is infiltrated by TLRexpressing inflammatory cells, whereas healthy gingivae display significantly lower levels of TLR expression (111, 112, 134) . Besides professional inflammatory cells, gingival epithelial cells and fibroblasts also express TLRs and the level of expression correlates with disease activity (94, 134, 162, 170) . In terms of function, TLRs (particularly TLR2, and to a much lesser extent TLR4) have been shown to regulate important immune and inflammatory responses to periodontal bacteria in vivo and in vitro (6, 15, 23, 30, 40, 57, 62, 121, 182) .
However, the precise roles, whether protective or destructive, played by the complement and the TLRs in periodontal infection and inflammation are poorly understood. This is partly because these issues have not yet been systematically investigated. Nevertheless, a substantial body of available literature exists, which, if properly synthesized and interpreted, could provide important new insights for future studies. Below, we aim to contribute to this direction by discussing pertinent studies from the oral microbiological and immunological literature. We will focus on major pathogens for which adequate literature exists on their interactions with both the complement and the TLR systems, namely, P. gingivalis, T. denticola, T. forsythia and P. intermedia.
P. gingivalis: master of subversion
In principle, a host inflammatory response can become destructive when it is deregulated and its magnitude spirals out of proportion to the microbial threat, or when it is undermined by pathogens, leading to persisting, but ineffective, inflammation in terms of infection control (43, 52, 93, 139) . In the context of periodontitis, P. gingivalis could be reasonably characterized as a master of subversion, on the basis of the sophisticated sabotage tactics presented below. This gram-negative anaerobic organism expresses an elaborate system of adhesins and proteolytic enzymes (e.g. long and short fimbriae, hemagglutinins, and Arg-and Lys-specific cysteine proteinases known as gingipains), which coordinately enable the pathogen to colonize host tissues and secure critical nutrients (97) . Important as these virulence features may be, P. gingivalis would probably be unable to establish a chronic infection, unless it could have also evolved ways to evade, undermine, or trick the host immune system. This is lucidly exemplified by its capacity to not only subvert both complement and TLR immunity but, moreover, to exploit crosstalk signaling pathways between complement and TLRs.
Neutralization of complement action
P. gingivalis causes significant inhibition of complement activation, regardless of the initiation pathway involved (classical, lectin, or alternative; Fig. 1 ), through gingipain-dependent degradation of key complement components, such as C3 (reviewed in refs 129, 155). As a consequence, the deposition of opsonins or of the membrane attack complex on the pathogen surface is suppressed, unless its gingipain activity is ablated by chemical or genetic means (145, 156) . All three gingipain enzymes participate in complement inactivation, although the Arg-specific enzymes (HRgpA and RgpB) are more potent in this regard than the Lys-specific gingipain (Kgp) (127) . As a further safety measure, the pathogen appears to hijack physiological mechanisms of inhibiting the complement cascade. In this regard, P. gingivalis uses its HRgpA to capture the circulating C4b-binding protein on the bacterial cell surface, thereby acquiring the ability to negatively regulate the classical pathway C3 convertase (131) .
The findings summarized above are consistent with the observations that P. gingivalis is exquisitely resistant to the lytic action of complement (127, 156) . Curiously, however, Arg-and Lys-gingipain mutants are as resistant as the wild-type organism upon their exposure to human serum, even though active complement fragments are readily deposited on their bacterial surface (156) . These intriguing observations suggest an inherent protective mechanism that is independent of complement inactivation. Indeed, a surface anionic polysaccharide was implicated in this inherent resistance because P. gingivalis mutants lacking this structure become readily susceptible to complement-mediated lysis (156) . Although this anionic polysaccharide may directly confer resistance, the possibility of an indirect effect may not formally be ruled out. In this context, certain pathogens (e.g. Helicobacter pylori and Escherichia coli) acquire resistance against complement-induced lysis by expressing molecules that can bind CD59, a host regulatory protein that inhibits the terminal step of membrane attack complex formation (96) .
It therefore appears that P. gingivalis may be using a number of different reinforcing mechanisms to ensure its survival in the presence of complement. In this regard, because the inhibitory mechanisms of P. gingivalis against complement activation are leaky (127) , it makes sense that it has also developed inherent resistance against complement-dependent lysis. However, if the surface anionic polysaccharide is sufficient to provide inherent protection, a plausible question is why the pathogen has evolved additional ways to suppress a system that cannot kill it. An interesting interpretation of this is that P. gingivalis may have evolved complement inactivation capacity not for its own protection, but for the benefit of other organisms occupying the same subgingival niche. This action may not be as altruistic as it seems; it may actually offer a survival advantage for P. gingivalis because it depends on other periodontal bacteria for enhanced colonization and full expression of virulence (81, 88, 126) . As P. gingivalis is resistant to the lytic action of complement (127, 156) , the ability of the complement system to directly offer host protection against this organism is seriously questioned. Nevertheless, it cannot be ruled out that complement activation may indirectly fight this pathogen through the recruitment and activation of phagocytic cells. However, as discussed in a later section (Exploitation of crosstalk interactions between TLRs and complement), P. gingivalis may have evolved strategies to diminish or evade its destruction by phagocytes in the presence of complement.
Evasion and subversion of TLRs
Currently available evidence suggests that P. gingivalis may have also evolved ways to evade or subvert the TLR system, which senses this organism primarily through TLR2, as shown in vitro and in vivo (15, 57) . However, TLR4 appears to play little or no role in cell activation in response to this oral bacterium (15, 57) . These observations appear curious given that P. gingivalis is a gram-negative organism which expresses a lipopolysaccharide. However, the organism elegantly utilizes specific lipid A 1-and 4¢-phosphatases and a deacylase, which, in concert, generate a tetra-acylated and dephosphorylated lipid A structure (21) . This modification renders the lipopolysaccharide molecule biologically inert, thereby allowing P. gingivalis to evade TLR4 activation (21) . At the same time, this modification confers protection against polymyxin B and perhaps other cationic antimicrobial peptides (21) . Intriguingly, the presence of high concentrations of hemin (an environmental nutrient found in diseased sites) suppresses lipid A 1-phosphatase activity and leads to the production of a monophosphorylated lipid A, which actively antagonizes TLR4 activation (21, 22) . Thus, even though P. gingivalis may express other molecules with intrinsic TLR4 agonistic activity, TLR4 activation is probably suppressed in the context of the whole organism (Fig. 3) , as seen both in vitro and in vivo (15, 57) . In this regard, P. gingivalis behaves like certain other, nonoral pathogens that have also opted to modify their surface structures in order to escape recognition by TLR4 (8, 109, 152) .
The above considerations may explain why TLR2, rather than TLR4, is the predominant TLR involved in recognition of P. gingivalis. Induction of TLR2 signaling by P. gingivalis requires a signaling partner (TLR1 or TLR6), takes place in membrane lipid rafts (where the receptors are recruited ad hoc) and is facilitated by a nonsignaling coreceptor (CD14) which constitutively resides in lipid rafts (57) . Although the host TLR2 response may be potentially protective, P. gingivalis has developed ways to undermine the intended host response. Indeed, the pathogen was shown to manipulate the TLR2 response by instigating a molecular crosstalk between TLR2 and the CXCchemokine receptor 4 in macrophage lipid rafts (62) . Specifically, the binding of P. gingivalis fimbriae to CXC-chemokine receptor 4 induces cyclic AMPdependent protein kinase A signaling, which in turn suppresses the TLR2-dependent activation of nuclear factor-jB and the induction of nitric oxide (Fig. 3 ) (62) . The inhibition of production of this key antimicrobial molecule promotes the ability of P. gingivalis to survive in vitro and in vivo (62) .
The impact of TLR2 signaling on the ability of P. gingivalis to cause experimental periodontitis was examined by two independent studies, which found that TLR2-deficient mice (but not TLR4-deficient mice or wild-type controls) are protected against periodontal bone loss (15, 47) . These findings are consistent with the notion that TLR2 signaling is manipulated by P. gingivalis in a way that promotes its virulence. However, an alternative or additional interpretation is that the observed enhanced bone loss in normal mice could be attributed to P. gingivalis induction of TLR2-mediated inflammatory osteoclastogenesis (169) .
Exploitation of crosstalk interactions between TLRs and complement
TLR2 activation by P. gingivalis induces two distinct signaling cascades (60) . One of the cascades leads to the induction of proinflammatory and antimicrobial responses, and represents the pathway that is manipulated by P. gingivalis through exploitation of CXC-chemokine receptor 4, as outlined above. The other cascade represents a pro-adhesive pathway and involves a crosstalk between TLR2 and the complement system (60). Specifically, P. gingivalis induces TLR2 inside-out signaling, which transactivates the adhesive capacity of complement receptor-3 (64) (Fig. 4 ). This crosstalk is made possible by the property of complement receptor-3 to cluster with TLRs in lipid rafts of P. gingivalis-stimulated cells (57) . Once transactivated, however, complement receptor-3 becomes a target of subversive activity by P. gingivalis.
Indeed, P. gingivalis uses its fimbriae to bind complement receptor-3, which in turn mediates the uptake of this oral pathogen by macrophages (59) . Intriguingly, this phagocytic mechanism does not promote the killing of P. gingivalis (171), possibly because complement receptor-3 is not linked to vigorous microbicidal mechanisms (139) . In contrast, when P. gingivalis is phagocytosed by alternative 
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Cell activation Fig. 3 . Evasion or subversion of Toll-like receptor (TLR) activation by Porphyromonas gingivalis. P. gingivalis uses an elaborate system of lipid A phosphatase and deacylase activities that modify the lipid A structure of its lipopolysaccharide (21, 22) . These modifications result in lipopolysaccharide molecules that can either evade or actively antagonize TLR4 activation (depicted as a homodimer; TLR4 ⁄ 4) (21, 22) . Although the activation of the TLR2 ⁄ TLR1 heterodimer (TLR2 ⁄ 1) is not antagonized at the TLR receptor level, P. gingivalis instigates a molecular crosstalk between the CXC-chemokine receptor 4 and TLR2 ⁄ 1. Unlike CD14, which facilitates TLR2 ⁄ 1 activation by the pathogen (57), CXCR4 suppresses TLR2 signaling (62). Mechanistically, P. gingivalis uses its fimbriae to bind CXCR4 and induce cyclic AMP-dependent protein kinase A (PKA) signaling, which in turn inhibits the activation of nuclear factor-kappaB (NF-jB) activation (62) .
receptors (i.e. when complement receptor-3 is blocked or genetically ablated), the intracellular killing of this pathogen is dramatically enhanced (171) . The interaction of P. gingivalis with complement receptor-3 also activates the extracellular signalregulated kinase 1 ⁄ 2, which in turn selectively inhibits expression of messenger RNA for the p35 and p40 subunits of interleukin-12 (56) (Fig. 4) . Interleukin-12 is a key cytokine involved in pathogen clearance through regulating the production of interferon-c, which is a potent activator of the macrophage microbicidal capacity (168) . Consistent with the above, wild-type mice elicit lower levels of interleukin-12 and interferon-gamma, and display impaired clearance of P. gingivalis systemic infection, compared with mice that lack complement receptor-3 (56) . Similar results are seen after CR3 blockade with a specific antagonist, which, furthermore, suppresses P. gingivalis induction of periodontal bone loss in mice (56) . In brief, there is compelling evidence that complement receptor-3 constitutes an AchillesÕ heel which confers host susceptibility to P. gingivalis infection. In this regard, it seems likely that P. gingivalis may have actually co-opted a natural anti-inflammatory mechanism to evade innate immunity. Specifically, complement receptor-3 is heavily committed with phagocytosis of iC3b-coated apoptotic cells, which are not normally recognized as danger (83, 107) . This precludes induction of a vigorous host response and, in fact, the production of interleukin-12 is inhibited following the phagocytosis of apoptotic cells by macrophages (83) .
Although P. gingivalis inhibits the complement cascade, curiously enough, the pathogen proactively generates one of the active complement fragments. Specifically, all three gingipains (HRgpA, RgpB and Kgp) act in a C5 convertase-like manner and generate biologically active C5a through the limited degrada- Crosstalk pathways between Toll-like receptors (TLRs) and complement in Porphyromonas gingivalisactivated macrophages. TLR recognition of P. gingivalis is predominantly mediated by the TLR2 ⁄ TLR1 heterodimer (TLR2 ⁄ 1), aided by the CD14 co-receptor (57) . This interaction induces phosphatidylinositol 3-kinase (PI3K)-dependent inside-out signaling, which transactivates the high-affinity state of complement receptor-3 (CR3) (54, 64) (CR3). Interestingly, P. gingivalis interacts with activated CR3 and induces extracellular signal-related kinase 1 ⁄ 2 (ERK1 ⁄ 2) signaling, which in turn downregulates the expression of messenger RNA for cytokines of the interleukin-12 family (56). Moreover, P. gingivalis uses its gingipains to attack C5 and release biologically active C5a (127, 176) . Through its receptor (C5aR), C5a can activate PI3K and ERK1 ⁄ 2, which in turn suppress critical transcription factors (the interferon regulatory factors 1 and 8; IRF-1 and -8), required for expression of cytokines of the interleukin-12 family (67). Intriguingly, inhibition of bioactive interleukin-12 though these mechanisms results in impaired immune clearance of P. gingivalis in vivo (56), suggesting that the pathogen exploits TLR ⁄ complement crosstalk signaling to promote its virulence.
tion of C5, whereas the C5b remnant is functionally inert (127, 176) . When C5 is oxidized by hydroxyl radicals (as may occur in the oxidative environment of the inflammatory response) the gingipains generate increased C5a biological activity (35) . Furthermore, P. gingivalis may indirectly generate functional C5a by exploiting the physiological crosstalk between the coagulation and the complement systems, which activates the so-called extrinsic pathway (71) (Fig. 1) . Indeed, HRgpA and RgpB activate prothrombin to form thrombin (73) , which, in turn, generates biologically active C5a by acting as a C5 convertase (71) (Fig. 1) . Although C5a can potentially play a key role in host defense against infection (50), it seems highly unlikely that P. gingivalis uses its enzymes to generate C5a to contribute to its elimination.
An intriguing question, therefore, is whether there is any selective pressure or advantage for P. gingivalis to specifically generate C5a, given that this chronically persisting pathogen overall inhibits the complement cascade. A possible scenario is that the local generation of excessive levels of C5a could incapacitate the antimicrobial function of gingival crevicular neutrophils, rendering them less threatening to P. gingivalis. This is because neutrophils become immunologically paralyzed in the presence of high concentrations (10-100 nm) of C5a and thereby fail to carry out functions such as chemotaxis, phagocytosis and production of antimicrobial and inflammatory mediators (72, 172) . Such immunological dysfunction has been seen both in vitro and in vivo and involves both human and rodent neutrophils (72, 136, 172) . In fact, C5a-mediated inhibition of neutrophil killing of P. gingivalis does occur, at least in vitro (J. Krauss and G. Hajishengallis, unpublished data). However, the underlying mechanisms, whether involving immune paralysis or alteration of specific signaling pathways, are currently under investigation. In addition to its potential exploitation by P. gingivalis, C5a may amplify periodontal tissue damage through its ability to recruit and activate inflammatory cells. For example, enhanced production of reactive oxygen species by C5a-stimulated neutrophils (50) may contribute to oxidative periodontal tissue destruction (19) . On the other hand, this host response would not affect P. gingivalis, because it is resistant to killing by reactive oxygen species (58, 113) .
Even if the gingipain activity of P. gingivalis is capable of increasing the microenviromental C5a concentrations to paralyzing levels for the neutrophils, this would not impinge on the function of macrophages, which can also be recruited to the gingival crevice or additionally interact with the pathogen in the periodontal connective tissue (33, 166) . Indeed, macrophages are quite resistant to the deleterious effects of high C5a concentrations, because they express relatively modest levels of the C5a receptor relative to the neutrophils (172) . For instance, whereas the ability of neutrophils to induce tumor necrosis factor-alpha (and other innate responses) is inhibited in the presence of C5a at concentrations of ‡10 nm, the macrophages display potentiated tumor necrosis factor-alpha responses under the same C5a concentrations (72, 136) .
Therefore, even at high levels, C5a does not exert a general immunosuppressive influence on macrophages. Strikingly, however, C5a can specifically downregulate cytokines of the interleukin-12 family. Indeed, C5a-induced signaling in macrophages interferes with TLR-induced expression of mRNA for the interleukin-12 p35, interleukin-12 ⁄ interleukin-23 p40 and interleukin-23 p19 subunits (67, 143) . These regulatory effects are possibly mediated through C5a-induced phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1 ⁄ 2 signaling, which in concert suppress critical transcription factors, namely the interferon regulatory factors 1 and 8 (67) (Fig. 4) . At the protein level, the production of interleukin-12 is inhibited both in vitro and in vivo, leading to suppression of T-helper type 1 cell-mediated immunity (67, 183) . Moreover, the ability of C5a to inhibit the expression of messenger RNA of both interleukin-23 subunits strongly suggests that C5a can interfere with the capacity of this cytokine to support the development of the T-helper type 17 cell subset (11) . The physiological significance of these C5a regulatory effects is likely to attenuate potential tissue damage mediated by T-helper type 1 and Thelper type 17 cells, as seen in various pathological inflammatory conditions (43, 101, 144) . However, undesirable outcomes may arise when C5a is not produced physiologically but through the uncontrolled action of microbial enzymes, such as the P. gingivalis gingipains. As interleukin-12 is important for immune control of P. gingivalis (56), it is possible that this pathogen may exploit the C5a-induced crosstalk with TLR2 for inhibiting IL-12-dependent immune clearance. Such an evasion mechanism may be complementary, rather than redundant, because the interaction of P. gingivalis with complement receptor-3 causes partial inhibition (about 60%) of interleukin-12 production (56). The notion that P. gingivalis hijacks C5a for its own benefit is additionally supported by observations that the intracellular survival of this pathogen in macrophages is promoted in the presence of C5a (M. Wang and G. Hajishengallis, unpublished observations).
Interestingly, unlike C5a, C3a is extensively degraded by P. gingivalis gingipains and does not retain biological activity (176) . Whether this is beneficial for the pathogen is uncertain, but it should be noted that C3a exerts direct antimicrobial effects and readily kills both gram-negative and gram-positive bacteria such as E. coli, Pseudomonas aeruginosa and Enterococcus faecalis (116) . If C3a can also kill P. gingivalis, then its gingipain-mediated inactivation would serve to protect P. gingivalis.
In summary, it appears that P. gingivalis does not have a purely defensive agenda in dealing with the complement system. In other words, the pathogen may not restrict its action to simply inhibiting the complement cascade, but rather may proactively employ specific complement components (such as the complement receptor-3 and the C5a) for bidirectional crosstalk interactions with TLR2 that favor the pathogen (Fig. 4) . These and other subversive mechanisms (for a review see refs 52, 129, 181) justify the characterization of P. gingivalis as a keynote periodontal pathogen, in that it can contribute virulence attributes that are essential for the survival of the entire biofilm community (28, 52).
T. denticola: spiraling out of control
In health, spirochetes (spiral-shaped bacteria with periplasmic flagella) inhabit the periodontal tissues at relatively low frequencies. In sharp contrast, a progressive decline in periodontal health correlates positively with a surge in the spirochete population, which constitutes a substantial percentage of the plaque microbiota in clinically diseased sites (38, 149) . Although their role in the initiation of periodontal diseases is uncertain, treponemes are literally at the forefront of established periodontal lesions in dominating numbers (38) . In particular, an elevation in the numbers of T. denticola, a relatively well-characterized oral spirochete, correlates with progressive disease activity and signifies a defining risk factor for advanced pocketing and periodontal attachment loss (149, 158) . Being a member of the red complex, T. denticola can engage in specific co-aggregating interactions with the other members (P. gingivalis and T. forsythia) and with F. nucleatum, mediated mostly by its 53-kDa major outer sheath protein (138, 149) .
The ability of T. denticola to colonize and invade the periodontium can be attributed, at least in part, to its remarkable motility, multiple adhesive properties and high proteolytic activity (18) . In this regard, dentilisin, a cell-surface adhesin with chymotrypsinlike properties, appears to facilitate the invasion of connective tissues via the degradation of epithelial cell tight junctions (20) . Moreover, dentilisin promotes bacterial invasion of the gingivae by activating matrix metalloproteinases to degrade the extracellular matrix, a mechanism, which at the same time, contributes to periodontal tissue destruction (34, 38) . However, the capacity of T. denticola to chronically persist in periodontal tissues suggests that the pathogen may have evolved additional ways to inactivate or escape immune-defense mechanisms. In this context, we review below its interactions with the complement and the TLR systems.
Complementary employment of the enemyÕs arsenal
Because of its potentially destructive effect on host tissues, complement activation is tightly controlled by membrane-bound proteins as well as by soluble regulatory host proteins. One such soluble control protein is factor H, a 155-kDa glycoprotein that controls the alternative pathway by inhibiting the formation of, and accelerating the decay of, the alternative pathway C3 convertase (2). Moreover, factor H contributes to the cleavage and inactivation of C3b to iC3b, and thus can attenuate the activation of the classical pathway C5 convertase and the downstream proinflammatory events (2) .
Although the most direct way whereby pathogens can inhibit complement activation involves the use of virulence proteases that degrade and inactivate complement components, another mechanism of evasion depends upon the ability of the pathogen to hijack and employ circulating complement regulators (96) . In this regard, T. denticola expresses an 11.4-kDa cell-surface lipoprotein that can bind factor H (104). This factor H-binding protein has little or no homology to other bacterial virulence proteins with similar function, suggesting convergent evolution for possible evasion of the complement system. Strikingly, however, once full-length factor H becomes associated with T. denticola, the organism uses its serine protease dentilisin to generate a 50-kDa factor H fragment that remains attached to the bacterial surface (104) . This seems paradoxical because dentilisin appears to negate the action of the factor H-binding protein. However, the dentilisin-mediated proteolysis of factor H is quite slow as this complement protein remains essentially intact after 40 min and complete digestion requires 1h (104) . Because complement activation is a remarkably rapid process, there is plenty of useful time during which T. denticola can escape complement killing by means of surface-bound, biologically active factor H. An interesting question that remains unanswered is whether the attached fragment retains useful complement-regulatory activity or whether it might be employed to serve a different virulence role. What is quite certain, however, is that proactive acquisition of factor H and its proteolytic processing would not be selected if it was detrimental for the pathogen.
The T. denticola dentilisin can also use another complement component as substrate, to generate a biologically active fragment. Specifically, this bacterial enzyme generates iC3b upon hydrolysis of the a chain of C3 (179) . This is consistent with an early study showing that T. denticola is readily opsonized with iC3b (146) . As iC3b-opsonized bacteria are taken up by phagocytes via complement receptor-3, it would seem counterproductive for a pathogen to help the host generate even more iC3b. However, as alluded to above, iC3b-mediated phagocytosis is often associated with weak killing mechanisms, or even with immunosuppressive signaling (10, 83, 107, 177) , which may be exploited by certain pathogens. Indeed, in addition to P. gingivalis discussed above, other microbial pathogens, such as Mycobacterium tuberculosis, Bordetella pertussis and human immunodeficiency virus-1 (HIV-1), promote their survival by exploiting complement receptor-3-mediated entry, either by direct interaction with the receptor or upon opsonization with iC3b (39, 68, 96) .
In summary, although T. denticola definitely cannot prevent the initiation of the complement cascade (146) , it may be protected from its killing potential by hijacking and employing specific downregulatory factors or specific opsonins for safe intracellular entry. However, additional functional studies are warranted to confirm these plausible mechanisms. Intriguingly, even if T. denticola was unable to resist complement-dependent killing successfully, its coexistence with P. gingivalis in shared niches (158) may provide it with effective protection mechanisms. In vivo observations in mouse models, that mixed infections with both pathogens are more virulent than monoinfections (80, 81, 85) , are consistent with this notion, although the precise synergistic mechanisms operating in vivo have not been elucidated.
Interactions with TLRs: paying a Toll to escape?
Studies in gingival epithelial cells, macrophages and transfected cell lines have shown that T. denticola activates TLR2, rather than TLR4 (5, 13, 117, 141) . When purified molecules of T. denticola were examined for cell activation, the major outer sheath protein was confirmed to be a TLR2 agonist, although its lipooligosaccharide induced the production of cytokines and nitric oxide in a TLR4-dependent, but TLR2-independent, manner (117) . It is uncertain at present whether the lipooligosaccharide is not properly exposed on the bacterial cell surface or if the pathogen possesses TLR4-antagonistic activity, similarly to P. gingivalis (22) , as a means to evade TLR4 activation. Although macrophages readily elicit cytokine production in response to T. denticola (117, 141) , gingival epithelial cells stimulated with the same pathogen fail to induce interleukin-8 (5, 13). Whereas degradation of this cytokine may in part explain the findings (5), it appears that the inhibitory mechanism in the epithelial cells is mainly exerted at the transcriptional level (13) . As gingival epithelial cell production of interleukin-8 is important for chemoattraction and activation of neutrophils, T. denticola appears to be capable of proactively suppressing or delaying the neutrophil influx. Such a mechanism, if indeed operating in vivo, would be most important, especially in the initial stages of the infection process (i.e. before a relatively recalcitrant pathogenic biofilm has been established). The capacity to suppress interleukin-8 production, as well as to inhibit induction of the human beta-defensin 2 (13) , is consistent with observations that the pathogen is frequently seen in close association with the gingival epithelium (38) . Moreover, the T. denticola mechanism to suppress TLR2-induced production of interleukin-8 is reminiscent of the so-called Ôlocal chemokine paralysisÕ mechanism used by P. gingivalis (29) .
Interestingly, T. denticola may use an additional mechanism to prevent the influx of neutrophils into its niche. Specifically, its major outer sheath protein was shown to impair Rac1-dependent neutrophil chemotaxis (102) . Rac1 is a small GTPase involved in various cellular functions and has a role in the activation of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase during the generation of the neutrophil oxidative burst (37) . Interestingly, T. denticola was shown to suppress the induction of this oxygen-dependent killing mechanism in neu-trophils (150) , which is a TLR-dependent function (142) . Whether the underlying mechanism involves the ability of T. denticola to inhibit Rac1 activity is uncertain, however. In addition to its roles in chemoattractant-induced directional motility (175) and the oxidative burst (37), Rac1 is also involved in the TLR2-induced activation of nuclear factor-kappaB (4). Thus, it would be interesting to determine whether the capacity of T. denticola to interfere with this central signaling regulator causes extensive, or even global, inhibition of the neutrophil antimicrobial function.
T. forsythia and P. intermedia vs. innate immunity: uncharted territories under exploration T. forsythia was described, in 1986, as a new species associated with periodontitis and was originally named Bacteroides forsythus (165) . Now, 23 years later, numerous clinical studies in humans, and animal model studies, have firmly confirmed the prominent role of this bacterium in the initiation and progression of periodontal disease (164) . As a member of the red complex (together with P. gingivalis and T. denticola), T. forsythia is considered a major periodontal pathogen. P. intermedia (formerly Bacteroides melaninogenicus ss. intermedius then Bacteroides intermedius), an obligatory anaerobic, black-pigmented, gram-negative rod, is frequently associated with adult periodontitis, acute necrotizing ulcerative gingivitis (Trench Mouth) and pregnancy gingivitis (27, 51) . This organism is also involved in extra-oral infections, including aspiration pneumonia and intraabdominal infection (9, 14) . P. intermedia is a member of the orange complex (158) but can also coaggregate with P. gingivalis and T. forsythia (79, 160) . Relatively little is known about how T. forsythia and P. intermedia interact with innate immunity, and only recently have studies been conducted to elucidate their interplay with complement and Toll-like receptors. The two bacteria will be examined together in the following sections.
T. forsythia and P. intermedia interactions with complement
Given the importance of T. forsythia in periodontitis, it is perplexing that literally nothing is known about how this pathogen interacts with complement.
Extensive search of PubMed, Medline, Web of Science and Scopus databases using the combination of key words Bacteroides forsythus ⁄ complement and Tannerella ⁄ complement revealed not even a single publication. As T. forsythia is exposed to complement in gingival crevicular fluid it can only be speculated that, like other major periodontopathic bacteria, the bacterium is either resistant to complement, or it is protected from the microbicidal activity of complement by other inhabitants of dental plaque (see below). Indeed, preliminary data strongly suggest that akin to other periodontopathogens, T. forsythia proteases may also play an essential role in neutralizing complement (M. Bojko, J. Potempa, K. Abdulkarim and A. Blom, unpublished results).
Several lines of evidence from early studies suggest that complement is a potentially important host defense mechanism against P. intermedia. First, heat inactivation of complement in normal human serum significantly reduces opsonic activity for P. intermedia (167) . Second, in the absence of the classical pathway, P. intermedia is opsonized by the alternative pathway, probably in response to its lipopolysaccharide (69, 120) . Nevertheless, the classical pathway is also important because kinetic studies have revealed that opsonization proceeds at significantly faster rates when the classical pathway is intact (167) . Third, different strains of P. intermedia show variable sensitivity to the complement-dependent bactericidal activity of serum (161) . Finally, the alternative pathway was shown to contribute to the killing of serum-sensitive strains, while the classical pathway was primarily responsible for killing strains with intermediate sensitivity (161) .
Interestingly, a number of Prevotella subspecies and strains, including P. intermedia, which have been associated with gingivitis and periodontitis, display higher proteolytic activity than that recorded for commensal strains isolated from healthy mouths (180) . This suggests that, akin to the gingipains of P. gingivalis, proteases produced by P. intermedia may also contribute to resistance against the antibacterial activity of complement. Indeed, recent and detailed investigations clearly implicate interpain A (InpA), a streptopain-like (SpeB-like) cysteine protease secreted by some P. intermedia strains, in conferring 100% resistance to killing by 20% normal human serum (130) . By contrast, an isogenic interpain A-deficient strain showed a survival rate of only 78% (130) . This protective effect is exerted by efficient degradation of complement factor C3, which is the central component of the entire complement system (Fig. 1) . Significantly, proteolytic inactivation of C3 by interpain A occurs in whole human serum, which explains the observation that opsonization and ⁄ or opsonization-dependent phagocytosis of E. coli and Proteus mirabilis are impaired when the serum is pretreated with certain Bacteroides species, including P. intermedia (77, 114, 167) .
Moreover, it appears that P. intermedia has developed additional, protease-independent strategies for evading killing by complement. This can be inferred from its significant survival rate, even when the bacterium is incubated with serum containing the broad-spectrum cysteine protease inhibitor, E-64 (128) . This inhibitor should ameliorate the proteolytic activity not only of interpain A, but also of two other streptopain-like proteases expressed by P. intermedia (128) . Although it cannot be excluded that serine proteinase activity, insensitive to E-64 inhibition (151), may be employed by P. intermedia to neutralize complement, it seems more likely that other mechanisms, such as binding of host-derived complement inhibitors, or the molecular composition of the bacterial surface, may confer exceptional resistance against complement-dependent lysis.
Oral bacterial co-aggregation is important for dental plaque formation, and P. intermedia has been shown to co-aggregate with P. gingivalis (78, 79) . In the context of this specific interaction and the general pathogenicity of biofilms, it becomes important to note that the interpain of P. intermedia synergizes with the gingipains of P. gingivalis in complement inactivation (130) . It is plausible that secreted interpain and gingipains aid in the survival of bystander bacterial species in dental plaque, which could otherwise be eliminated by the bactericidal activity of complement. This bacterial synergy may be one of the mechanisms that contribute to a favorable biofilm environment which could foster the survival of the entire microbial community.
In interacting with complement, P. intermedia shares one important feature with P. gingivalis. At low concentrations, the interpain, similarly to gingipains, is able to activate the C1 complex in serum, causing deposition of C1q on bacterial surfaces (130) . Furthermore, the interpain can directly release anaphylatoxin C3a, while gingipains additionally release C5a (127, 130) . Significantly, although high concentrations of these proteases inhibit the complement cascade, the anaphylatoxins are still released by direct protease action. Taken together, the following scenario can be envisioned (Fig. 5) . P. gingivalis and P. intermedia activate complement when present at low numbers, resulting in a local inflammatory reaction that does not eliminate them because these bacteria are resistant to complement-mediated lysis. However, complement activation can suppress complement-sensitive bacteria, which could otherwise compete for space and nutrients. The inflammatory serum exudate, moreover, provides P. gingivalis and P. intermedia with precious nutrients (such as hemin, a source of essential iron). At later stages of infection, the concentration of proteases is high enough to destroy C3 and inhibit complement activation, thus promoting the survival of the entire biofilm community by helping bystander bacteria evade complement killing. Even under these conditions that suppress the physiological activation of the complement cascade, the proactive release of biologically active C5a can stimulate inflammatory serum exudate for acquisition of hemin and other nutrients. Furthermore, because anaphylatoxins are potent mediators of inflammatory reactions (91), their local generation at sites heavily populated with bacteria can contribute to the pathological processes associated with periodontal tissue destruction. Moreover, C5a could be additionally exploited for immune evasion (see above, Exploitation of crosstalk interactions between TLRs and complement), thus further promoting pathogen survival and ensuing inflammation. It is thus becoming apparent that periodontal pathogens have evolved in ways that allow them to not only endure inflammation but exploit it for promoting their adaptive fitness, as long as they can shut down critical host responses [such as induction of nitric oxide production (62) ] that could eliminate them.
P. intermedia and T. forsythia interactions with TLRs
TLR-mediated recognition of P. intermedia and T. forsythia, and the subsequent activation of signal transduction pathways culminating in the generation of inflammatory cytokines, can have a direct bearing on periodontal pathogenesis. Unfortunately, our knowledge about TLR interactions with these two pathogens is limited. Similarly to P. gingivalis and T. denticola, which predominantly activate TLR2, P. intermedia and T. forsythia sonicates exclusively stimulate TLR2 in human cell lines transfected with various combinations of TLRs and co-receptors (82) . Consistent with these results, purified lipoproteins of T. forsythia and a nonendotoxic glycoprotein of P. intermedia activate TLR2 signaling in human monocytic THP-1 cells and ⁄ or human gingival fibroblasts (65, 159) . By contrast, highly purified lipid A, derived from the lipopolysaccharide of P. intermedia, activates murine peritoneal macrophages to secrete interleukin-6 through a TLR4-dependent pathway (66) . However, the fact that whole cells of P. intermedia fail to activate TLR4 (82) suggests the possible presence of TLR4 antagonistic activity associated with the bacterial cell surface, although this possibility has not been addressed.
In addition to lipoproteins, another cell surfaceassociated and secreted protein, the BspA of T. forsythia, also activates TLR2, resulting in the production of interleukin-1, interleukin-8 and tumor necrosis factor-alpha upon interactions with human gingival epithelial cells or human monocytic THP-1 cells (55, 121) . In the former interaction, TLR1 serves as a signaling partner (121) , whereas the latter interaction is additionally dependent on the CD14 co-receptor (55) . From a pathological point of view, it is important to note that T. forsythia, T. denticola and P. gingivalis can induce strongly synergistic interleukin-6 production (163). As interleukin-6 activates osteoclasts (74) , this synergistic A
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C1 complex activation and deposition of C1q on bacterial surfaces. P. intermedia and P. gingivalissurvive because they are resistant to complement lysis, but sensitive bacteria (in green), which could otherwise compete for space and nutrients, are killed in this process. Effects of low concentrations of the proteases (i.e. early in the colonization process), which activate the classical pathway. (B) Effects of high concentrations of the proteases (i.e. in a developed biofilm), which suppress the physiological activation of the complement cascade, but selectively generate anaphylatoxins via limited degradation of C3 and C5. P. gingivalis and P. intermedia are exceptionally resistant to the bactericidal activity of complement, and released proteases, gingipains and interpain, respectively, contribute to the resistance. At low concentrations of the proteases, likely to occur at the early stages of infection or at a long distance from the dental plaque, the released proteases activate the C1 complex, leading to deposition of C1q on the bacterial surface (127, 130) . Complement activation may eliminate complementsensitive commensal bacteria, which could otherwise compete with pathogens for space and nutrients. At high concentrations, the proteases synergistically inhibit the bactericidal activity of complement by degrading C3 and C5, thus protecting complement-sensitive bacteria in their proximity and promoting biofilm development. At the same time, released anaphylatoxins (C3a and C5a; although only the latter was confirmed to retain its biological activity) fuel inflammation, resulting in tissue damage and nutrient generation, and are exploited for immune evasion (see also Fig. 4) . P. gingivalis, Porphyromonas gingivalis; T. denticola, Treponema denticola.
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action may significantly reduce the number of bacteria required to stimulate alveolar bone resorption. This concept becomes biologically relevant in the light of recent evidence that the three pathogens synergize in inducing periodontal bone resorption in vivo (81) . Cumulatively, a large body of evidence indicates that periodontal bacteria preferentially activate immune and nonimmune cells using the TLR2 pathway (57, 82, 117, 141, 182) . TLR2 stimulation in the absence of simultaneous signaling through TLR4 favors the development of the T helper 2-type immune response (48, 132, 133) . Interestingly, the immune response in chronic periodontitis is strongly T helper 2-type biased and is strongly associated with the progressive lesion of periodontitis (44, 45) . Therefore, it is reasonable to hypothesize that preferential stimulation of TLR2 by periodontal pathogens contributes to the T helper 2-type skewing of the immune response, which may perpetuate chronic inflammation and periodontal disease progression, as opposed to the T helper 1-type immune response, which is more effective in bacterial clearance by professional phagocytes (43) . Additional reasons for this TLR2 ÔpreferenceÕ may be related to observations that a number of pathogens, including P. gingivalis (see above), have evolved mechanisms for successfully dealing with the outcome of TLR2-dependent cell activation (62, 122, 124, 154, 174) . Although there is no compelling evidence that the TLR4 response is necessarily more protective against infection relative to TLR2, it is interesting to note that TLR4, but not TLR2 (as either a TLR2 ⁄ 1 or TLR2 ⁄ 6 heterodimer), activates autophagy in a way that eliminates phagocytosed pathogens by macrophages (32) . A notable known exception among oral bacteria that preferentially activate TLR2 is Aggregatibacter actinomycetemcomitans, which readily activates TLR4 (82, 182) . However, unlike bacteria such as P. gingivalis, T. denticola, and P. intermedia, which may survive by suppressing selective aspects of the host response, A. actinomycetemcomitans appears to promote its persistence by elaborating powerful toxins (e.g. leukotoxin and cytolethal distending toxin), which are capable of killing both innate and adaptive immune effector cells (reviewed in ref. 87 ).
Conclusions and future directions
As discussed above, complement and TLRs function as major defense systems against microbial infection, whether acting separately or in concert (103, 105, 183) . However, in the course of evolution, successful pathogens have ÔlearnedÕ to breach these systems and exploit their communication hubs (96, 140) . Table 1 summarizes putative virulence mechanisms whereby periodontal pathogens may resist or escape complement-and TLR-mediated immunity. These microbial strategies may explain, at least in part, the ability of periodontal bacteria, such as P. gingivalis, T. denticola, T. forsythia and P. intermedia, to persist and establish chronic infections in the otherwise hostile environment of their host. As these bacteria reside in mixed-species biofilms, it is reasonable to assume a synergy of shared, communal mechanisms of immune subversion to maximize the survival potential of the whole community, a concept that is supported by evidence initially available. This also suggests that even bacteria lacking protective mechanisms on their own may thrive in such environment, as long as their presence is beneficial to the immune-subversive bacteria. For example, although no immune-evasion mechanisms have been reported for F. nucleatum, this bacterium is a useful member of the tooth-associated biofilm by forming a coaggregating bridge between early and late colonizers (92) , and can chronically persist in deep periodontal pockets (158) .
The analysis of pertinent literature in this review also reveals gaps, especially at the mechanistic level, in our understanding of periodontal bacterial immune evasion. In addition to molecular mechanistic studies that may help to identify novel virulence factors, in vivo studies are also warranted to substantiate some of the in vitro findings. Although this review has focused on the host defense potential of the complement and the TLRs, and how this is undermined by periodontal bacteria, it should also be noted that both systems contribute to immunopathology in several inflammatory diseases (100, 135) . However, relatively little is known regarding the precise roles of the complement and the TLRs in periodontal pathogenesis. Consequently, it is currently uncertain which specific signaling pathways need to be blocked to attenuate the pathology or, conversely, be enhanced to promote host defense. At a first stage, these gaps in our knowledge necessitate mechanistic and interventional studies using appropriate animal models, because causal mechanistic relationships cannot normally be addressed in human studies for important ethical considerations (49) . Successful elucidation of the roles of complement and TLRs in immune and inflammatory responses in the periodontium, and how these are proactively modified by peri-odontal pathogens, will offer insights into periodontal pathogenesis and facilitate the rational design of therapeutic interventions.
